このエントリーをはてなブックマークに追加
ID 13365
Sort Key
2
FullText URL
Thumnail 118_9.pdf 9.22 MB
Author
梅岡 達生
川嶋 健
寺石 文則
滝 正樹
京 哲
永井 勝幸
浦田 泰生
田中 紀章
藤原 俊義 ORCID Kakenhi
Keywords
GFP
アデノウイルス
テロメラーゼ
増幅
遺伝子治療
Note
平成16年度岡山医学会賞(林原賞)受賞論文
Publication Title
岡山医学会雑誌
Published Date
2006-05-01
Volume
volume118
Issue
issue1
Publisher
岡山医学会
Publisher Alternative
Okayama Medical Association
Start Page
9
End Page
15
ISSN
0030-1558
NCID
AN00032489
Content Type
Journal Article
OAI-PMH Set
岡山大学
language
日本語
Copyright Holders
Copyright© 岡山医学会
File Version
publisher
Refereed
True
DOI
NAID
Eprints Journal Name
joma
References
1) Tearney GJ, Brezinski ME, Bouma BE, Boppart SA, Pitris C, Southern JF and Fujimoto JG: In vivo endoscopic optical biopsy with optical coherence tomography. Science (1997) 276, 2037-2039.
2) MacDonald SL and Hansell DM: Staging of non-small cell lung cancer: imaging of intrathoracic disease. Eur J Radiol (2003) 45, 18-30.
3) Misteli T and Spector DL: Applications of the green fluorescent protein in cell biology and biotechnology. Nat Biotechnol (1997) 15, 961-964.
4) van Roessel P and Brand AH: Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins. Nat Cell Biol (2002) 4, E 15-20.
5) Ehrhardt D: GFP technology for live cell imaging. Curr Opin Plant Biol (2003) 6, 622-628.
6) Rashidi B, Yang M, Jiang P, Baranov E, An Z, Wang X, Moossa AR and Hoffman RM: A highly metastatic Lewis lung carcinoma orthotopic green fluorescent protein model. Clin Exp Metastasis (2000) 18, 57-60.
7) Yang M, Baranov E, Jiang P, Sun FX, Li XM, Li L, Hasegawa S, Bouvet M, Al-Tuwaijri M, Chishima T, Shimada H, Moossa AR, Penman S and Hoffman RM: Whole-body optical imaging of green fluorescent proteinexpressing tumors and metastases. Proc Natl Acad Sci USA (2000) 97, 1206-1211.
8) Hoffman RM: Visualization of GFP-expressing tumors and metastasis in vivo. Biotechniques (2001) 30, 1016-1022, 1024-1026.
9) Bouvet M, Wang J, Nardin SR, Nassirpour R, Yang M, Baranov E, Jiang P, Moossa AR and Hoffman RM: Realtime optical imaging of primary tumor growth and multiple metastatic events in a pancreatic cancer orthotopic model. Cancer Res (2002) 62, 1534-1540.
10) Yamamoto N, Yang M, Jiang P, Tsuchiya H, Tomita K, Moossa AR and Hoffman RM: Real-time GFP imaging of spontaneous HT-1080 fibrosarcoma lung metastases. Clin Exp Metastasis (2003) 20, 181-185.
11) Kawashima T, Kagawa S, Kobayashi N, Shirakiya Y, Umeoka T, Teraishi F, Taki M, Kyo S, Tanaka N and Fujiwara T: Telomerase-specific replication-selective virotherapy for human cancer. Clin Cancer Res (2004) 10, 285-292.
12) Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL and Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science (1994) 266, 2011-2015.
13) Shay JW and Wright WE: Telomerase activity in human cancer. Curr Opin Oncol (1996) 8, 66-71.
14) Shay JW and Wright WE: Telomerase: a target for cancer therapeutics. Cancer Cell (2002) 2, 257-265.
15) Uno F, Fujiwara T, Takata Y, Ohtani S, Katsuda K, Takaoka M, Ohkawa T, Naomoto Y, Nakajima M and Tanaka N: Antisense-mediated suppression of human heparanase gene expression inhibits pleural dissemination of human cancer cells. Cancer Res (2001) 61, 7855-7860.
16) Shao J, Fujiwara T, Kadowaki Y, Fukazawa T, Waku T, Itoshima T, Yamatsuji T, Nishizaki M, Roth JA and Tanaka N: Overexpression of the wild-type p53 gene inhibits NF-kB activity and synergizes with aspirin to induce apoptosis in human colon cancer cells. Oncogene (2000) 19, 726-736.
17) Waku T, Fujiwara T, Shao J, Itoshima T, Murakami T, Kataoka M, Gomi S, Roth JA and Tanaka N: Contribution of CD95 ligand-induced neutrophil infiltration to the bystander effect in p53 gene therapy for human cancer. J Immunol (2000) 165, 5884-5890.
18) Itoshima T, Fujiwara T, Waku T, Shao J, Kataoka M, Yarbrough WG, Liu TJ, Roth JA, Tanaka N and Kodama M: Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation. Clin Cancer Res (2000) 6, 2851-2859.
19) Ohtani S, Kagawa S, Tango Y, Umeoka T, Tokunaga N, Tsunemitsu Y, Roth JA, Taya Y, Tanaka N and Fujiwara T: Quantitative analysis of p53-targeted gene expression and visualization of p53 transcriptional activity following intratumoral administration of adenoviral p53 in vivo. Mol Cancer Ther (2004) 3, 93-100.